NY-AQARA
29.2.2024 09:01:34 CET | Business Wire | Press release
Aqara, a leading provider of smart home solutions, is thrilled to announce the expansion of its smart lighting product line with the introduction of the Ceiling Light T1M. This smart light fixture seamlessly blends radiant white lights with a colorful gradient ring for everyday and atmospheric illumination. The Ceiling Light T1M is available on Aqara’s Amazon brand stores in North America (US, Canada) and Europe (France, Germany, Italy, Poland, Spain, UK) as well as through select Aqara retailers worldwide*.
Designed for rooms ranging from 5 to 20 square meters (approximately 54 to 215 square feet), this ceiling light offers a versatile lighting solution. With a spectrum ranging from warm-to-cool whites (2700-6500K) to an impressive 16 million colors, users can effortlessly create the perfect ambiance for any mood or occasion. Moreover, its independently addressable RGB ring enables seamless integration into holistic smart home experiences, allowing users to visually receive notifications or alerts regarding their home’s status changes, such as when someone rings the Aqara doorbell or triggers an armed security system. For hearing-impaired individuals, the T1M Ceiling Light can be paired with smart security alarm systems to add customized visual alerts, further enhancing the safety and convenience for users.
Similar to other Aqara Zigbee devices, the Ceiling Light T1M supports Matter and other major platforms, such as Apple Home (including Adaptive Lighting for HomeKit users), Amazon Alexa, and Google Home, via a compatible Aqara hub*. The wide compatibility positions it as a future-proof addition to any space. The ceiling light features low idle power consumption thanks to the energy-efficient Zigbee protocol, while also serving as a repeater of the Zigbee network, enhancing network range and responsiveness. Zigbee also ensures local automation to remain functional even when the ceiling light is disconnected from the internet. Engineered for excellence, the T1M features a Color Rendering Index (Ra) of 90 for true-to-life hues and has undergone rigorous testing to ensure a lifespan of 50,000 hours for longevity.
Expanding upon the success of the LED Strip T1, the Ceiling Light T1M represents the latest addition to Aqara's smart light portfolio, furthering the Company's commitment to creating the ultimate smart home experience. With smart light being an integral part of a truly smart home, the T1M harmonizes with other Aqara devices to elevate everyday living. For example, the T1M can be paired with presence or motion sensors for automated illumination, which helps cut energy waste. Moreover, by coupling it with an Aqara light switch, which features Wireless Switch mode, users can enjoy the familiarity of traditional light control while preserving the sophistication of the Ceiling Light's smart functionality.
For more information on the Ceiling Light T1M, please visit our website.
* Product availability may vary among different retail channels and could be updated on an ongoing basis. It’s recommended to check with the regional retailer(s) for real-time availability.
** The Matter compatibility of the Ceiling Light T1M requires a Matter-compatible Aqara hub (e.g., Hub M2, Hub M1S/M1S Gen 2, Hub E1, Camera Hub G3) and may be in Beta by the time of its launch.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240229437381/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press release
The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL)Positive trends toward progression-free survival (PFS) benefit with tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypesThe frontMIND data support the submission of global regulatory applications for tafasitamab and lenalidomide added to R-CHOP for previously untreated DLBCLThe data are being presented in an oral session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The Lancet* Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating t
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom